Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis.

ABSTRACT:

Background

Modelling suggests that achieving the WHO incidence target for hepatitis C virus (HCV) elimination in Pakistan could cost US$3.87 billion over 2018 to 2030. However, the economic benefits from integrating services or improving productivity were not included.

Methods and findings

We adapt a HCV transmission model for Pakistan to estimate the impact, costs, and cost-effectiveness of achieving HCV elimination (reducing annual HCV incidence by 80% by 2030) with stand-alone service delivery, or partially integrating one-third of initial HCV testing into existing healthcare services. We estimate the net economic benefits by comparing the required investment in screening, treatment, and healthcare management to the economic productivity gains from reduced HCV-attributabl

SUBMITTER: Lim AG 

PROVIDER: S-EPMC8525773 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature